Europe Blood Plasma Derivatives Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Type (Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin), By Country and Growth Forecast, 2022 - 2028

Europe Blood Plasma Derivatives Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Type (Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin), By Country and Growth Forecast, 2022 - 2028

The Europe Blood Plasma Derivatives Market would witness market growth of 9.1% CAGR during the forecast period (2022-2028).

Plasma, or blood plasma, is the liquid component of blood. Plasma functions as a transport medium for providing nutrients to the cells of the different organs of the body and for transferring metabolic waste products to the liver, kidneys, and lungs for elimination. It is also a blood cell transport mechanism and plays a crucial function in maintaining appropriate blood pressure.

Plasma helps maintain homeostasis, also called biological stability, including the acid-base balance within the blood and organism. Blood cells, including white blood cells (leukocytes), red blood cells (erythrocytes), and platelets (thrombocytes), are isolated from whole blood to produce plasma. The residual straw-colored fluid comprises a significant amount of water, but it also includes essential solutes required for life. Electrolytes, like sodium, potassium, magnesium, bicarbonate, and calcium are important ingredients.

In addition, traces of amino acids, organic acids, vitamins, pigments, and enzymes are present. The endocrine system secretes hormones such as corticosteroids, insulin, and thyroxine into the blood. Hormone plasma concentrations must be carefully managed for optimal health. With renal failure, the amount of nitrogenous wastes (such as urea and creatinine) delivered to the kidney for excretion increases significantly.

The increasing government, as well as international support in the European countries in order to improve plasma research and uses, would accelerate the growth of the blood plasma derivatives market in the region. FDA has MRAs in place with the European Union and the United Kingdom. Since 2014, the FDA and the EU have partnered to study how each authority inspects drug producers and the risks and advantages of mutual recognition of drug inspections. The increasing focus of government along with various public organizations would drive the growth of the regional market.

The Germany market dominated the Europe Blood Plasma Derivatives Market by Country in 2021; thereby, achieving a market value of $4,815.1 Million by 2028. The UK market is exhibiting a CAGR of 8.2% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 9.9% during (2022 - 2028).

Based on Application, the market is segmented into Immunodeficiency Diseases, Hypogammaglobulinemia, Hemophilia, Von Willebrand's Disease, and Others. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Biotest AG, LFB S.A., CSL Limited, Octapharma AG, Kedrion S.p.A, Sanofi S.A. and Fusion Health Care Pvt. Ltd.

Scope of the Study

Market Segments covered in the Report:

By Application

• Immunodeficiency Diseases
• Hypogammaglobulinemia
• Hemophilia
• Von Willebrand's Disease
• Others

• Hospitals
• Clinics
• Others

• Immunoglobulin
• Albumin
• Factor VIII
• Factor IX
• Hyperimmune Globulin
• Others

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

• Bayer AG
• Takeda Pharmaceutical Company Limited
• Grifols, S.A.
• Biotest AG
• LFB S.A.
• CSL Limited
• Octapharma AG
• Kedrion S.p.A
• Sanofi S.A.
• Fusion Health Care Pvt. Ltd.

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free